In March 2010, we began offering Xoft Electronic Brachytherapy (eBx), a breakthrough radiation therapy for early stage breast cancer, skin cancer, and some gynecologic cancers. Xoft eBx is an alternative to radioactive isotope-based brachytherapy. It utilizes a miniaturized X-ray source to deliver precisely localized, high dose radiation to the target area, at low energy.

Treatment can be performed without the need for a shielded room, allowing the radiation oncologist and other medical personnel to be present during treatment delivery which can minimize patient anxiety. Xoft eBx allows for the radiation to be ‘more tightly’ focused around the tumor target which helps protect healthy organs and tissue. One of the biggest benefits to Xoft eBx is that is it requires fewer sessions than traditional radiation. Treatment for early stage breast cancer, skin cancer, and some gynecologic cancers can often be accomplished in as little as 5 sessions. Xoft eBx eliminates the use of radioactive isotopes, resulting in less exposure to radiation, fewer side effects, and excellent outcomes for patients.